Search

Your search keyword '"Baldari S."' showing total 13 results
Start Over Author "Baldari S." Journal annals of oncology
13 results on '"Baldari S."'

1. 1394P Alkaline phosphatase (ALP) decline and pain response as markers for overall survival (OS) in patients (Pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (223Ra) in the REASSURE study

Author

O'Sullivan, J., primary, Heinrich, D., additional, Castro Marcos, E., additional, George, S., additional, Song, D.Y., additional, Dizdarevic, S., additional, Baldari, S., additional, Essler, M., additional, de Jong, I.J., additional, Lastoria, S., additional, Hammerer, P.G., additional, Tombal, B., additional, James, N.D., additional, Verholen, F., additional, Meltzer, J., additional, Sandström, P., additional, and Sartor, O., additional

Published
2022
Full Text
View/download PDF

5. Use of bone health agents (BHAs) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) after abiraterone (Abi): An interim review of REASSURE

Author

Sternberg, C.N., primary, Tombal, B., additional, Miller, K., additional, Saad, F., additional, Sartor, O., additional, Sade, J.P., additional, Logothetis, C., additional, Bellmunt, J., additional, Dizdarevic, S., additional, Harshman, L.C., additional, Logue, J., additional, Baldari, S., additional, Richardson, T., additional, Bottomley, D., additional, Schostak, M., additional, Bayh, I., additional, Kalinovsky, J., additional, and Higano, C., additional

Published
2018
Full Text
View/download PDF

6. Tumour growth rate (TGR) when using lanreotide Autogel® (LAN) before, during and after peptide receptor radionuclide therapy (PRRT) in advanced neuroendocrine tumours (NETs)

Author

Prasad, V., primary, Srirajaskanthan, R., additional, Grana, C.M., additional, Baldari, S., additional, Shah, T., additional, Lamarca, A., additional, Courbon, F., additional, Scheidhauer, K., additional, Baudin, E., additional, Truong-Thanh, X.-M., additional, Houchard, A., additional, and Bodei, L., additional

Published
2018
Full Text
View/download PDF

7. Radium-223 with concomitant bone-targeting agents in metastatic castration-resistant prostate cancer (CRPC) patients treated in an international early access program (EAP)

Author

Paganelli, G., primary, Procopio, G., additional, Cabria, M., additional, Cortesi, E., additional, Tucci, M., additional, Farnesi, A., additional, Mango, L., additional, Baldari, S., additional, Hamzaj, A., additional, Caffo, O., additional, Marchetti, P., additional, Dalla Pozza, F., additional, Zucali, P., additional, Barsanti, R., additional, and Saad, F., additional

Published
2017
Full Text
View/download PDF

8. Patient (pt) characteristics and treatment patterns in the radium (Ra)-223 REASSURE observational study

Author

Baldari, S., primary, Annibale, V., additional, Lastoria, S., additional, Tucci, M., additional, Borsatti, E., additional, Monari, F., additional, Paganelli, G., additional, Verri, E., additional, Muto, P., additional, Panareo, S., additional, Mosca, A., additional, Storto, G., additional, Bagnato, A., additional, Farsad, M., additional, Bilancia, D., additional, Marchetti, P., additional, Sternberg, C., additional, Procopio, G., additional, Seregni, E., additional, and Valdagni, R., additional

Published
2017
Full Text
View/download PDF

9. Changes in alkaline phosphatase (ALP) dynamics and overall survival (OS) in metastatic castration-resistant prostate cancer (mCRPC) patients treated with radium-223 in an international early access program (EAP)

Author

Procopio, G., primary, Paganelli, G., additional, Cabria, M., additional, Cortesi, E., additional, Tucci, M., additional, Farnesi, A., additional, Mango, L., additional, Baldari, S., additional, Hamzaj, A., additional, Caffo, O., additional, Marchetti, P., additional, Dalla Pozza, F., additional, Zucali, P., additional, Barsanti, R., additional, and Heinrich, D., additional

Published
2017
Full Text
View/download PDF

10. Analysis of overall survival by number of radium-223 injections received in an international expanded access program (iEAP)

Author

Paganelli, G., primary, Procopio, G., additional, Cabria, M., additional, Cortesi, E., additional, Tucci, M., additional, Farnesi, A., additional, Mango, L., additional, Baldari, S., additional, Hamzaj, A., additional, Caffo, O., additional, Marchetti, P., additional, Dalla Pozza, F., additional, Zucali, P.A., additional, Saad, F., additional, Nilsson, S., additional, and Heinrich, D., additional

Published
2016
Full Text
View/download PDF

12. 826P - Use of bone health agents (BHAs) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (Ra-223) after abiraterone (Abi): An interim review of REASSURE

Author

Sternberg, C.N., Tombal, B., Miller, K., Saad, F., Sartor, O., Sade, J.P., Logothetis, C., Bellmunt, J., Dizdarevic, S., Harshman, L.C., Logue, J., Baldari, S., Richardson, T., Bottomley, D., Schostak, M., Bayh, I., Kalinovsky, J., and Higano, C.

Published
2018
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results